Back
Grifols SA Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Buy
81
GRFS
Grifols SA
Last Price:
7.01
Seasonality Move:
2.3%
Sell
26
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
0.93
Seasonality Move:
-23.05%
Buy
81
Grifols SA (GRFS)
is a Buy
Is Grifols SA a Buy, Sell or Hold?
- The current Grifols SA [GRFS] share price is $7.00. The Score for GRFS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- GRFS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
26
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.92. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRFS Stock Price Chart
What is Grifols SA's stock price today?
-
The Grifols SA share price today is $7.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRFS is experiencing slight buying pressure.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $0.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
GRFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.25 | Buy |
| Chaikin Money Flow: | 237004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.38 - 6.94) | Buy |
| Bollinger Bands (100): | (6.19 - 9.23) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.81 | Sell |
| Chaikin Money Flow: | -153052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.2) | Sell |
| Bollinger Bands (100): | (0.94 - 2.08) | Sell |
GRFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.79 | Buy |
| 20-day SMA: | 6.59 | Buy |
| 50-day SMA: | 6.55 | Buy |
| 200-day SMA: | 8.57 | Sell |
| 8-day EMA: | 6.81 | Buy |
| 20-day EMA: | 6.7 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 8.06 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1 | Sell |
| 50-day SMA: | 1.09 | Sell |
| 200-day SMA: | 3 | Sell |
| 8-day EMA: | 1.04 | Sell |
| 20-day EMA: | 1.05 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 39.34 | Sell |
Grifols SA Earnings Growth & GRFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.86 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Grifols SA Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||